Wound Care Biologics

Wound Care Biologics

Global Wound Care Biologics Market to Reach US$5.0 Billion by 2030

The global market for Wound Care Biologics estimated at US$2.6 Billion in the year 2023, is expected to reach US$5.0 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2023-2030. Biologic Skin Substitutes, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$3.1 Billion by the end of the analysis period. Growth in the Topical Agents segment is estimated at 8.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$684.5 Million While China is Forecast to Grow at 13.9% CAGR

The Wound Care Biologics market in the U.S. is estimated at US$684.5 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.3 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 8.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Wound Care Biologics Market - Key Trends and Drivers Summarized

In the evolving landscape of medical treatments, wound care biologics represent a significant advancement, introducing a blend of natural and synthetic biomaterials to enhance the healing process. Wound care biologics refer to the use of biologically derived materials, such as growth factors, skin substitutes, and tissue-based products, to facilitate the healing of wounds. These biologics are primarily used to treat complex wounds that do not heal easily through traditional methods, including diabetic ulcers, burns, and severe lacerations. By harnessing the natural healing capabilities of biological materials, wound care biologics promote tissue regeneration and accelerate the recovery process, making them an essential component of advanced wound management strategies. Wound healing is facilitated by a sophisticated interplay of cellular and extracellular components, growth factors, and matrix metalloproteinases, which are often compromised in chronic wounds. Wound care biotechnology aims to address these deficits by introducing biologically active treatments to the wound site. Among the most promising are cell-based therapies, which utilize the regenerative capabilities of stem cells such as keratinocytes, fibroblasts, and adipose-derived stromal cells. These are applied as either autologous or allogeneic grafts to enhance the wound bed`s receptiveness to healing.

Skin substitutes play a crucial role in managing non-healing wounds, offered as either temporary or permanent solutions and are categorized into acellular and cellular products. The latter involves living cells integrated within a matrix, aiding in faster and more effective wound closure. Moreover, the application of exogenous growth factors such as recombinant human platelet-derived growth factor-BB (rhPDGF-BB) has become instrumental in stimulating repair processes, though their success largely depends on the wound bed`s condition. Additionally, the development of bioartificial scaffolds that mimic the skin`s extracellular matrix highlights the shift towards more sophisticated wound care approaches. These scaffolds, incorporating biological components such as collagen and hyaluronic acid, not only support but actively promote healing, distinguishing them from traditional wound dressings.Recent trends in the wound care biologics market reflect a growing focus on personalized medicine and cost-effective treatment options. There is a notable shift towards allogeneic therapies, where biologic materials are sourced from donors rather than from the patients themselves, which can reduce costs and simplify treatment protocols. Moreover, regulatory support for biologic-based therapies is expanding, with numerous products receiving fast-track designations and approvals from bodies such as the FDA.

 Global increase in the prevalence of diabetes and the corresponding rise in diabetic ulcers  continues to fuel the demand for effective wound healing solutions. As diabetic patients often experience reduced healing capabilities, biologics play a crucial role in managing chronic wounds and preventing complications. Advancements in biotechnology have enabled the development of more effective and efficient biologic treatments that can significantly reduce healing times and improve patient outcomes. These advancements include innovations in growth factor technology, genetically engineered skin substitutes, and cultured epithelial autografts. Additionally, the aging global population, which is more susceptible to chronic conditions that impair wound healing, further increases the demand for biologic treatments.

Select Competitors (Total 42 Featured) -
  • Acell
  • Anika Therapeutics
  • Integra Lifesciences
  • Kerecis
  • Marine Polymer Technologies
  • Mimedx Group
  • Mölnlycke Health Care AB (Investor AB)
  • Organogenesis
  • Osiris Therapeutics
  • Smith & Nephew
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Global Economic Update
Wound Care Biologics - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Chronic Wounds and Diabetes-related Ulcers
Increasing Demand for Advanced Biological Wound Care Solutions
Technological Advancements in Biologic Wound Care Products
Growth in Surgical Procedures and Trauma Cases
Emergence of Stem Cell-based and Regenerative Therapies
Increasing Focus on Infection Control and Antimicrobial Biologics
Increasing Focus on Personalized and Targeted Wound Care Solutions
Role of Wound Care Biologics in Reducing Healing Time and Improving Outcomes
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Wound Care Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Biologic Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Biologic Skin Substitutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Biologic Skin Substitutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Topical Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Topical Agents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Topical Agents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Ulcers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Ulcers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Surgical & Traumatic Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Surgical & Traumatic Wounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Surgical & Traumatic Wounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Burns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Burns by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Burns by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for ASCs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for ASCs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Burn Centers & Wound Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Burn Centers & Wound Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Burn Centers & Wound Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
TABLE 28: World Wound Care Biologics Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 29: USA Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: USA Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: USA 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: USA Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: USA 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 35: USA Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: USA Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: USA 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Canada Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Canada 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 41: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: Canada Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: Canada 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: Canada Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: Canada 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
JAPAN
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 47: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Japan Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Japan 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 51: Japan Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Japan 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 53: Japan Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Japan Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Japan 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
CHINA
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 56: China Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: China Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: China 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 59: China Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: China Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: China 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 62: China Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: China Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: China 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
EUROPE
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 65: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 66: Europe Historic Review for Wound Care Biologics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Europe 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Europe Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Europe 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 71: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Europe Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Europe 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 74: Europe Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: Europe Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: Europe 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
FRANCE
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 77: France Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: France Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: France 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 80: France Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: France Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: France 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 83: France Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: France Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: France 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
GERMANY
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 86: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Germany Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Germany 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 89: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Germany Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Germany 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 92: Germany Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Germany Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Germany 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
ITALY
TABLE 95: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Italy Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Italy 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 98: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 99: Italy Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 100: Italy 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 101: Italy Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 102: Italy Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 103: Italy 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
UNITED KINGDOM
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 104: UK Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 105: UK Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 106: UK 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 107: UK Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 108: UK Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 109: UK 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 110: UK Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 111: UK Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 112: UK 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
SPAIN
TABLE 113: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 114: Spain Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 115: Spain 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 116: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 117: Spain Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 118: Spain 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 119: Spain Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 120: Spain Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 121: Spain 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
RUSSIA
TABLE 122: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 123: Russia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 124: Russia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 125: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 126: Russia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 127: Russia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 128: Russia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 129: Russia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 130: Russia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 135: Rest of Europe Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 136: Rest of Europe 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 138: Rest of Europe Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 139: Rest of Europe 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Wound Care Biologics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 144: Asia-Pacific Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 145: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 147: Asia-Pacific Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 148: Asia-Pacific 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 150: Asia-Pacific Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 151: Asia-Pacific 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
AUSTRALIA
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
TABLE 152: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 153: Australia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 154: Australia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 155: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 156: Australia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 157: Australia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 158: Australia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 159: Australia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 160: Australia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
INDIA
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
TABLE 161: India Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 162: India Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 163: India 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 164: India Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 165: India Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 166: India 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 167: India Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 168: India Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 169: India 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
SOUTH KOREA
TABLE 170: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 171: South Korea Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 172: South Korea 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 173: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 174: South Korea Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 175: South Korea 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 176: South Korea Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 177: South Korea Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 178: South Korea 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
REST OF ASIA-PACIFIC
TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 180: Rest of Asia-Pacific Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 183: Rest of Asia-Pacific Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 186: Rest of Asia-Pacific Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
LATIN AMERICA
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
TABLE 188: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 189: Latin America Historic Review for Wound Care Biologics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 190: Latin America 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
TABLE 191: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 192: Latin America Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 193: Latin America 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 194: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 195: Latin America Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 196: Latin America 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 197: Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 198: Latin America Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 199: Latin America 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
ARGENTINA
TABLE 200: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 201: Argentina Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 202: Argentina 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 203: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 204: Argentina Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 205: Argentina 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 206: Argentina Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 207: Argentina Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 208: Argentina 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
BRAZIL
TABLE 209: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 210: Brazil Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 211: Brazil 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 212: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 213: Brazil Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 214: Brazil 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 215: Brazil Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 216: Brazil Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 217: Brazil 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
MEXICO
TABLE 218: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 219: Mexico Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 220: Mexico 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 221: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 222: Mexico Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 223: Mexico 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 224: Mexico Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 225: Mexico Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 226: Mexico 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
REST OF LATIN AMERICA
TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 228: Rest of Latin America Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 229: Rest of Latin America 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 231: Rest of Latin America Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 232: Rest of Latin America 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 234: Rest of Latin America Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 235: Rest of Latin America 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
MIDDLE EAST
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
TABLE 236: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 237: Middle East Historic Review for Wound Care Biologics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 238: Middle East 16-Year Perspective for Wound Care Biologics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
TABLE 239: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 240: Middle East Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 241: Middle East 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 242: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 243: Middle East Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 244: Middle East 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 245: Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 246: Middle East Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 247: Middle East 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
IRAN
TABLE 248: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 249: Iran Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 250: Iran 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 251: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 252: Iran Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 253: Iran 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 254: Iran Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 255: Iran Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 256: Iran 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
ISRAEL
TABLE 257: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 258: Israel Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 259: Israel 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 260: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 261: Israel Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 262: Israel 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 263: Israel Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 264: Israel Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 265: Israel 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
SAUDI ARABIA
TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 267: Saudi Arabia Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 268: Saudi Arabia 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 270: Saudi Arabia Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 271: Saudi Arabia 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 273: Saudi Arabia Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 274: Saudi Arabia 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
UNITED ARAB EMIRATES
TABLE 275: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 276: UAE Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 277: UAE 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 278: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 279: UAE Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 280: UAE 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 281: UAE Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 282: UAE Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 283: UAE 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
REST OF MIDDLE EAST
TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 285: Rest of Middle East Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 286: Rest of Middle East 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 288: Rest of Middle East Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 289: Rest of Middle East 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 291: Rest of Middle East Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 292: Rest of Middle East 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
AFRICA
Wound Care Biologics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
TABLE 293: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 294: Africa Historic Review for Wound Care Biologics by Product - Biologic Skin Substitutes and Topical Agents Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 295: Africa 16-Year Perspective for Wound Care Biologics by Product - Percentage Breakdown of Value Sales for Biologic Skin Substitutes and Topical Agents for the Years 2014, 2024 & 2030
TABLE 296: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 297: Africa Historic Review for Wound Care Biologics by Wound Type - Ulcers, Surgical & Traumatic Wounds and Burns Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 298: Africa 16-Year Perspective for Wound Care Biologics by Wound Type - Percentage Breakdown of Value Sales for Ulcers, Surgical & Traumatic Wounds and Burns for the Years 2014, 2024 & 2030
TABLE 299: Africa Recent Past, Current & Future Analysis for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 300: Africa Historic Review for Wound Care Biologics by End-Use - Hospitals, ASCs and Burn Centers & Wound Clinics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 301: Africa 16-Year Perspective for Wound Care Biologics by End-Use - Percentage Breakdown of Value Sales for Hospitals, ASCs and Burn Centers & Wound Clinics for the Years 2014, 2024 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings